Literature DB >> 33490703

Obesity and gut microbiome: review of potential role of probiotics.

Francine Schütz1, Margarida Figueiredo-Braga2,3, Pedro Barata4,5, Natália Cruz-Martins1,5,6.   

Abstract

Obesity prevalence has increased worldwide over the years, with pandemic levels being already reached, besides to its huge economic and health impacts. The multifactorial pathogenesis of obesity partly explains the important challenge posed to health policy regarding its clinical treatment, with increasing evidences have shown that obesity and metabolic disturbances are closely linked to variations in gut microbiota (GM) function and composition. Indeed, GM play a key contribution in energy metabolism, with GM modulation being increasingly linked to changes in body weight and body mass index. In such matter, probiotics have been proposed as a promising new therapeutic strategy to treat/prevent obesity. Thus, this review aims to provide an overview on the clinical impact and effectiveness of probiotics in obese individuals.
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of PBJ-Associação Porto Biomedical/Porto Biomedical Society. All rights reserved.

Entities:  

Keywords:  gut microbiota; health promotion; inflammation; obesity; probiotics

Year:  2021        PMID: 33490703      PMCID: PMC7817278          DOI: 10.1097/j.pbj.0000000000000111

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN: 2444-8664


  57 in total

1.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

Review 2.  Understanding the role of gut microbiome in metabolic disease risk.

Authors:  Yolanda Sanz; Marta Olivares; Ángela Moya-Pérez; Carlo Agostoni
Journal:  Pediatr Res       Date:  2014-10-14       Impact factor: 3.756

3.  Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduces fasting triglycerides and enhances apolipoprotein A-V levels in non-diabetic subjects with hypertriglyceridemia.

Authors:  Hyeon Yeong Ahn; Minjoo Kim; Jey Sook Chae; Young-Tae Ahn; Jae-Hun Sim; Il-Dong Choi; Sang-Hyun Lee; Jong Ho Lee
Journal:  Atherosclerosis       Date:  2015-06-18       Impact factor: 5.162

4.  Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Authors:  Zohreh Karbaschian; Zeinab Mokhtari; Abdolreza Pazouki; Ali Kabir; Mahdi Hedayati; Somayeh Soleymanzadeh Moghadam; Parvin Mirmiran; Azita Hekmatdoost
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

5.  Metabolic endotoxemia initiates obesity and insulin resistance.

Authors:  Patrice D Cani; Jacques Amar; Miguel Angel Iglesias; Marjorie Poggi; Claude Knauf; Delphine Bastelica; Audrey M Neyrinck; Francesca Fava; Kieran M Tuohy; Chantal Chabo; Aurélie Waget; Evelyne Delmée; Béatrice Cousin; Thierry Sulpice; Bernard Chamontin; Jean Ferrières; Jean-François Tanti; Glenn R Gibson; Louis Casteilla; Nathalie M Delzenne; Marie Christine Alessi; Rémy Burcelin
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

6.  Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice.

Authors:  Suzanne Devkota; Yunwei Wang; Mark W Musch; Vanessa Leone; Hannah Fehlner-Peach; Anuradha Nadimpalli; Dionysios A Antonopoulos; Bana Jabri; Eugene B Chang
Journal:  Nature       Date:  2012-07-05       Impact factor: 49.962

7.  Effect of probiotic (VSL#3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: a randomized, controlled trial.

Authors:  Hemalatha Rajkumar; Naseha Mahmood; Manoj Kumar; Sudarshan Reddy Varikuti; Hanumanth Reddy Challa; Shiva Prakash Myakala
Journal:  Mediators Inflamm       Date:  2014-03-26       Impact factor: 4.711

8.  SCFAs strongly stimulate PYY production in human enteroendocrine cells.

Authors:  P Larraufie; C Martin-Gallausiaux; N Lapaque; J Dore; F M Gribble; F Reimann; H M Blottiere
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

9.  Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals.

Authors:  Marina Sanchez; Christian Darimont; Shirin Panahi; Vicky Drapeau; André Marette; Valerie H Taylor; Jean Doré; Angelo Tremblay
Journal:  Nutrients       Date:  2017-03-15       Impact factor: 5.717

Review 10.  Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?

Authors:  Chencheng Xie; Dina Halegoua-DeMarzio
Journal:  Nutrients       Date:  2019-11-19       Impact factor: 5.717

View more
  7 in total

1.  Probiotic Foods Are Effective on Weight Loss, Biochemical Parameters, and Intestinal Microbiota in Wistar Albino Rats with Obese Microbiota.

Authors:  Nadide Gizem Tarakci; Nihal Zekiye Erdem; Emek Dumen
Journal:  Int J Clin Pract       Date:  2022-03-03       Impact factor: 3.149

Review 2.  New Understanding of Diagnosis, Treatment and Prevention of Endometriosis.

Authors:  Bedayah Amro; Maria Eugenia Ramirez Aristondo; Shaima Alsuwaidi; Basma Almaamari; Zeinab Hakim; Muna Tahlak; Arnaud Wattiez; Philippe R Koninckx
Journal:  Int J Environ Res Public Health       Date:  2022-05-31       Impact factor: 4.614

Review 3.  Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives.

Authors:  Monica Barone; Federica D'Amico; Marco Fabbrini; Simone Rampelli; Patrizia Brigidi; Silvia Turroni
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

Review 4.  Recent Advances in Understanding the Structure and Function of the Human Microbiome.

Authors:  Walaa K Mousa; Fadia Chehadeh; Shannon Husband
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

Review 5.  Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics.

Authors:  Jonathan Breton; Marie Galmiche; Pierre Déchelotte
Journal:  Microorganisms       Date:  2022-02-16

6.  Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.

Authors:  Young Gyu Cho; Yun Jun Yang; Yeong Sook Yoon; Eon Sook Lee; Jun Hyung Lee; Yulah Jeong; Chang Ho Kang
Journal:  Nutrients       Date:  2022-08-30       Impact factor: 6.706

7.  The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People.

Authors:  Inna Burakova; Yuliya Smirnova; Mariya Gryaznova; Mikhail Syromyatnikov; Pavel Chizhkov; Evgeny Popov; Vasily Popov
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.